International Biotechnology (LON:IBT – Get Free Report)’s share price crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of GBX 1,039.37 and traded as high as GBX 1,065. International Biotechnology shares last traded at GBX 1,030, with a volume of 61,640 shares trading hands.
International Biotechnology Price Performance
The company has a market cap of £324.44 million, a PE ratio of 4.24 and a beta of 0.46. The business has a 50 day moving average of GBX 1,098.90 and a 200 day moving average of GBX 1,040.32. The company has a debt-to-equity ratio of 9.43, a current ratio of 0.11 and a quick ratio of 0.32.
About International Biotechnology
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.
Further Reading
- Five stocks we like better than International Biotechnology
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
